Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: GLENMARK PHARMACEUTICALS USA
Client-Reported Lobbying Expenses
$4.9M
33 filings
Summary
GLENMARK PHARMACEUTICALS USA is an organization, based in NJ. Its political footprint includes $4.9 million in client-reported lobbying expenses. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark, Taxation/Internal Revenue Code. Political activity spans from 2017 to 2024.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Activity data: Senate LDA